Body Awareness Therapy and Biomarkers in Fibromyalgia
ConditionFibromyalgia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversitat de Lleida
About this trial
A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.
Eligibility criteria
Qualifiers
whose diagnosed of fibromyalgia almost 6 months before
whose could be in different position such as lying, sitting, and stand-up
Disqualifiers
whose are diagnosed of disease that it worse the pain
pregnancy
whose are diagnosed of other disease such as rheumatology, neurology, cardiac problems o another internal medical condition,malignant disease or acute infections
Trial design
Treatments tested in this trial
- Basic Body Awareness Therapy
- Stretching Exercise
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Universitat de Lleida
Lead sponsor
Consorci Sanitari de l'Anoia
Collaborator
Source ClinicalTrials.gov